How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Flavonoids Market
- By Source: Citrus Fruits, Soybeans, Tea Leaves, Onion Skins, Apples
- By Type: Flavonols, Flavones, Flavanones, Isoflavones, Anthocyanidins, Flavanols
- By Application: Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Cosmetics, Animal Feed
- By Form: Powder, Liquid Extract, Capsules/Tablets, Granules
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Citrus Fruits leads By Source at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.169 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.177 →
Full report · locked preview
Everything inside the Flavonoids Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Indena S.p.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Dabur India Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nutraceutical Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Sabinsa Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Glanbia Nutritionals
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Frutarom Industries Ltd. (International Flavors & Fragrances)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Nexira
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Naturex (a Givaudan company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Euromed S.A.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Martin Bauer Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Arjuna Natural Pvt Ltd
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Herbalife Nutrition Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Milei S.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Parchem Fine & Specialty Chemicals
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Xi'an Sost Biotech Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Citrus Fruits53.5
- Soybeans14.6
- Tea Leaves8.9
- Onion Skins7.9
- Apples15.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Indena S.p.A.20.7
- Dabur India Ltd.13.5
- Nutraceutical Corporation10.7
- Sabinsa Corporation8.4
- Glanbia Nutritionals10.2
- Frutarom Industries Ltd. (International Flavors & Fragrances)8.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.9
- Europe22.8
- Asia Pacific19.4
- Latin America12.0
- Middle East and Africa10.0
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Indena S.p.A. | 95 | 73 | 79 | 84 | 95 | 73 | 83 |
| Dabur India Ltd. | 93 | 68 | 69 | 79 | 76 | 87 | 79 |
| Nutraceutical Corporation | 83 | 64 | 68 | 79 | 62 | 62 | 70 |
| Sabinsa Corporation | 63 | 81 | 65 | 71 | 81 | 63 | 71 |
| Glanbia Nutritionals | 59 | 69 | 72 | 57 | 62 | 69 | 65 |
| Frutarom Industries Ltd. (International Flavors & Fragrances) | 52 | 63 | 70 | 55 | 61 | 67 | 61 |
| Nexira | 58 | 62 | 55 | 51 | 54 | 45 | 54 |
| Naturex (a Givaudan company) | 57 | 41 | 46 | 57 | 57 | 41 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Indena S.p.A.
- Dabur India Ltd.
- Nutraceutical Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Indena S.p.A. | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Dabur India Ltd. | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Nutraceutical Corporation | ✓ | − | ✓ | ◐ | ◐ | ◐ |
| Sabinsa Corporation | ✓ | ◐ | ◐ | ◐ | ✓ | − |
| Glanbia Nutritionals | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Frutarom Industries Ltd. (International Flavors & Fragrances) | − | ◐ | ✓ | − | − | ◐ |
| Nexira | ◐ | ✓ | − | − | ◐ | ◐ |
| Naturex (a Givaudan company) | − | − | ◐ | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Source in North America, then scale across Flavonoids Market — a $78M beachhead inside a $1.53B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Citrus Fruits
Best fit — highest urgency & budget in Source.
Soybeans
Strong fit — clear ROI and a fast path to value.
Tea Leaves
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Source leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Flavonoids Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Flavonoids Market is a durable-growth opportunity — $1.62B by 2033, compounding at 7.4%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.4% CAGR
Demand compounds through 2033, outpacing GDP across Source.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Flavonoids Market — a $4.30B market by 2033. Plan: grow share from 8.2% to 13.7%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.2% | 13.7% | Ahead |
| Revenue | $377M | $590M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 37.5% | 42.1% | Ahead |
| Customer retention | 87.9% | 95.7% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Source
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Type capability
A defensible second engine — invest in Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $79M capacity & capability investment
- Greenlight bolt-on M&A in Type
- Authorise North America expansion plan
- Fund R&D program for Source leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentOn track
Sales deck · value proposition
Win the Flavonoids Market conversation — a $4.90B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source
Goal Grow share in Source
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Flavonoids Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Flavonoids Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Sn-2 Palmitate Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportFluoropolymer Additives Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportDrive-Through Portal (DTP) X-ray Systems Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportDrive-through COVID-19 Testing Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportCapsaicin Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportGlucosamine Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportPharmaceutical Aluminum Tube Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportInjection Bottles Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportMedical PEEK Polymers Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportHydroxybenzoate Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportAmbroxol API Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportEbastine Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy